Impact of Diabetes on Cardiac Sympathetic Innervation in Patients With Heart Failure: A 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study

Blockade of β-adrenoceptors restores the GRK2-mediated adrenal α2-adrenoceptor-catecholamine production axis in heart failure

(2012) G Rengo et al.   BRITISH JOURNAL OF PHARMACOLOGY

Myocardial β2-adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure

(2012) G Rengo et al.   BRITISH JOURNAL OF PHARMACOLOGY

Targeting the β-Adrenergic Receptor System Through G-Protein–Coupled Receptor Kinase 2: A New Paradigm for Therapy and Prognostic Evaluation in Heart Failure

(2012) Giuseppe Rengo et al.   Circulation-Heart Failure

Cardiac Iodine-123 Metaiodobenzylguanidine (123I-MIBG) Scintigraphy Parameter Predicts Cardiac and Cerebrovascular Events in Type 2 Diabetic Patients Without Structural Heart Disease

(2011) Kunio Yufu et al.   CIRCULATION JOURNAL

Standards of Medical Care in Diabetes--2012

(2011)   DIABETES CARE

Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal

(2011) P. Perrone-Filardi et al.   HEART

Adrenal Beta-Arrestin 1 Inhibition In Vivo Attenuates Post-Myocardial Infarction Progression to Heart Failure and Adverse Remodeling Via Reduction of Circulating Aldosterone Levels

(2011) Anastasios Lymperopoulos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Influence of Diabetes Mellitus on Prognostic Utility of Imaging of Myocardial Sympathetic Innervation in Heart Failure Patients

(2010) Myron C. Gerson et al.   Circulation-Cardiovascular Imaging

Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of 123I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability

(2010) Arthur J. H. A. Scholte et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology

(2010) Albert Flotats et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Reduction of Sympathetic Activity via Adrenal-targeted GRK2 Gene Deletion Attenuates Heart Failure Progression and Improves Cardiac Function after Myocardial Infarction

(2010) Anastasios Lymperopoulos et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

GRK2 as a novel gene therapy target in heart failure

(2010) Giuseppe Rengo et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Cardiac Sympathetic Denervation Assessed With 123-Iodine Metaiodobenzylguanidine Imaging Predicts Ventricular Arrhythmias in Implantable Cardioverter-Defibrillator Patients

(2010) Mark J. Boogers et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failure

(2010) Arnold F. Jacobson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Multidimensional Prognostic Index Based on a Comprehensive Geriatric Assessment Predicts Short-Term Mortality in Older Patients With Heart Failure

(2009) Alberto Pilotto et al.   Circulation-Heart Failure

Modulation of Adrenal Catecholamine Secretion by In Vivo Gene Transfer and Manipulation of G Protein–coupled Receptor Kinase-2 Activity

(2008) Anastasios Lymperopoulos et al.   MOLECULAR THERAPY